Operating Income Summary of Bioqual, Inc.

Bioqual, Inc.'s latest annual operating income in 2023 was -19.63 Thousand USD , down -101.78% from previous year.
Bioqual, Inc.'s latest quarterly operating income in 2024 Q1 was -1.13 Million USD , up 43.17% from previous quarter.
Bioqual, Inc. reported an annual operating income of 1.1 Million USD in 2022, down -83.12% from previous year.
Bioqual, Inc. reported an annual operating income of 6.53 Million USD in 2021, down -23.66% from previous year.
Bioqual, Inc. reported a quarterly operating income of -1.99 Million USD for 2023 Q4, down -922.95% from previous quarter.
Bioqual, Inc. reported a quarterly operating income of 241.96 Thousand USD for 2023 Q3, down -56.98% from previous quarter.

Annual Operating Income Chart of Bioqual, Inc. (2023 - 1995)

Historical Annual Operating Income of Bioqual, Inc. (2023 - 1995)

Year	Operating Income	Operating Income Growth
2023	-19.63 Thousand USD	-101.78%
2022	1.1 Million USD	-83.12%
2021	6.53 Million USD	-23.66%
2020	8.55 Million USD	60.78%
2019	5.32 Million USD	48.5%
2018	3.58 Million USD	-32.03%
2017	5.27 Million USD	-19.42%
2016	6.54 Million USD	38.61%
2015	4.72 Million USD	45.5%
2014	3.24 Million USD	73.86%
2013	1.86 Million USD	1622.21%
2012	-122.61 Thousand USD	0.0%
2010	677.84 Thousand USD	0.08%
2009	677.27 Thousand USD	0.0%
2006	1.58 Million USD	37.72%
2005	1.15 Million USD	-10.19%
2004	1.28 Million USD	13.75%
2003	1.12 Million USD	28.03%
2002	881.5 Thousand USD	0.0%
2000	568.85 Thousand USD	141.96%
1999	235.1 Thousand USD	-55.57%
1998	529.12 Thousand USD	600.33%
1997	75.55 Thousand USD	1.25%
1996	74.61 Thousand USD	-52.59%
1995	157.38 Thousand USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	-1.13 Million USD	43.17%
2023 Q4	-1.99 Million USD	-922.95%
2023 Q3	241.96 Thousand USD	-56.98%
2023 Q1	1.16 Million USD	209.79%
2023 Q2	562.45 Thousand USD	-51.81%
2022 Q3	-1.61 Million USD	-188.4%
2022 Q2	1.82 Million USD	-6.57%
2022 Q1	1.95 Million USD	10.69%
2022 FY	1.1 Million USD	-83.12%
2022 Q4	-1.06 Million USD	34.14%
2021 Q4	1.76 Million USD	45.89%
2021 FY	6.53 Million USD	-23.66%
2021 Q3	1.21 Million USD	-24.87%
2021 Q1	1.94 Million USD	-25.63%
2021 Q2	1.61 Million USD	-17.21%
2020 Q1	2.49 Million USD	98.66%
2020 Q3	1.37 Million USD	-33.21%
2020 Q4	2.61 Million USD	89.71%
2020 FY	8.55 Million USD	60.78%
2020 Q2	2.06 Million USD	-17.28%
2019 FY	5.32 Million USD	48.5%
2019 Q3	992.42 Thousand USD	-19.08%
2019 Q1	1.84 Million USD	40.9%
2019 Q4	1.25 Million USD	26.62%
2019 Q2	1.22 Million USD	-33.58%
2018 Q3	643.32 Thousand USD	-15.5%
2018 Q1	868.74 Thousand USD	-39.65%
2018 FY	3.58 Million USD	-32.03%
2018 Q4	1.31 Million USD	103.72%
2018 Q2	761.32 Thousand USD	-12.36%
2017 Q3	1.18 Million USD	-6.44%
2017 FY	5.27 Million USD	-19.42%
2017 Q1	1.43 Million USD	-10.09%
2017 Q2	1.27 Million USD	-11.37%
2017 Q4	1.43 Million USD	21.07%
2016 Q1	1.74 Million USD	-17.04%
2016 FY	6.54 Million USD	38.61%
2016 Q3	1.45 Million USD	-17.04%
2016 Q4	1.59 Million USD	9.27%
2016 Q2	1.75 Million USD	0.69%
2015 FY	4.72 Million USD	45.5%
2015 Q4	2.1 Million USD	96.52%
2015 Q3	1.07 Million USD	-12.24%
2015 Q2	1.22 Million USD	189.27%
2015 Q1	422.15 Thousand USD	-50.41%
2014 Q4	851.3 Thousand USD	37.05%
2014 FY	3.24 Million USD	73.86%
2014 Q1	783.12 Thousand USD	39.25%
2014 Q2	989.3 Thousand USD	26.33%
2014 Q3	621.15 Thousand USD	-37.21%
2013 FY	1.86 Million USD	1622.21%
2013 Q4	562.38 Thousand USD	4.98%
2013 Q2	356.1 Thousand USD	19.82%
2013 Q3	535.72 Thousand USD	50.44%
2013 Q1	297.2 Thousand USD	189.62%
2012 Q3	-478.54 Thousand USD	-568.86%
2012 Q4	102.61 Thousand USD	121.44%
2012 Q2	102.06 Thousand USD	0.0%
2012 FY	-122.61 Thousand USD	0.0%
2011 Q1	469.49 Thousand USD	29.01%
2010 FY	677.84 Thousand USD	0.08%
2010 Q4	363.91 Thousand USD	144.58%
2010 Q3	148.79 Thousand USD	-15.85%
2010 Q1	-11.67 Thousand USD	-108.37%
2010 Q2	176.81 Thousand USD	1614.06%
2009 FY	677.27 Thousand USD	0.0%
2009 Q4	139.54 Thousand USD	-35.95%
2009 Q3	217.86 Thousand USD	209.94%
2009 Q2	70.29 Thousand USD	0.0%
2006 Q3	592.9 Thousand USD	115.85%
2006 Q4	78.72 Thousand USD	-86.72%
2006 Q2	274.68 Thousand USD	-57.18%
2006 Q1	641.52 Thousand USD	510.8%
2006 FY	1.58 Million USD	37.72%
2005 Q3	338.38 Thousand USD	106.42%
2005 Q2	163.93 Thousand USD	-69.95%
2005 FY	1.15 Million USD	-10.19%
2005 Q1	545.58 Thousand USD	0.0%
2005 Q4	105.03 Thousand USD	-68.96%
2004 FY	1.28 Million USD	13.75%
2003 FY	1.12 Million USD	28.03%
2002 FY	881.5 Thousand USD	0.0%
2001 Q1	166.77 Thousand USD	-33.5%
2001 Q2	132.05 Thousand USD	-20.82%
2001 Q3	151.88 Thousand USD	15.02%
2000 Q4	250.78 Thousand USD	167.99%
2000 FY	568.85 Thousand USD	141.96%
2000 Q3	93.57 Thousand USD	-29.62%
2000 Q2	132.95 Thousand USD	45.25%
2000 Q1	91.53 Thousand USD	-23.35%
1999 FY	235.1 Thousand USD	-55.57%
1999 Q4	119.42 Thousand USD	293.0%
1999 Q2	48.28 Thousand USD	0.0%
1999 Q3	30.38 Thousand USD	-37.06%
1998 FY	529.12 Thousand USD	600.33%
1997 FY	75.55 Thousand USD	1.25%
1996 FY	74.61 Thousand USD	-52.59%
1995 FY	157.38 Thousand USD	0.0%

Peer Operating Income Comparison of Bioqual, Inc.

Name	Operating Income	Operating Income Difference
American Bio Medica Corporation	-1.24 Million USD	98.419%
Arrayit Corporation	-3.62 Million USD	99.458%
Atlantic International Corp.	-5.73 Million USD	99.657%
Biocept, Inc.	-31.98 Million USD	99.939%
CardioGenics Holdings Inc	-772.14 Thousand USD	97.457%
DermTech, Inc.	-103.73 Million USD	99.981%
Global WholeHealth Partners Corporation	- USD	Infinity%
Hangzhou Tigermed Consulting Co., Ltd.	2.48 Billion USD	100.001%
HTG Molecular Diagnostics, Inc.	-20.82 Million USD	99.906%
iMD Companies, Inc.	-175.44 Thousand USD	88.807%
IDenta Corp.	-1499.00 USD	-1210.073%
Interpace Biosciences, Inc.	2.8 Million USD	100.7%
Integrative Health Technologies, Inc.	38.69 Thousand USD	150.757%
InVitro International	-25.33 Thousand USD	22.499%
Lumos Diagnostics Holdings Limited	-7.12 Million USD	99.724%
Many Bright Ideas Technologies Inc.	-58.11 Thousand USD	66.207%
Medical Imaging Corp.	-819.48 Thousand USD	97.604%
NovelStem International Corp.	-3.52 Million USD	99.443%
Optigenex Inc.	1.39 Million USD	101.412%
PharmChem, Inc.	973.14 Thousand USD	102.018%
Proteome Sciences plc	-1.62 Million USD	98.789%
Response Genetics, Inc	-21.37 Million USD	99.908%
Rennova Health, Inc.	-1.4 Million USD	98.607%
RushNet, Inc.	-684.7 Thousand USD	97.132%
ScreenPro Security Inc.	-2.59 Million USD	99.242%
Stella Diagnostics Inc.	-11.42 Million USD	99.828%
StageZero Life Sciences Ltd.	-7.74 Million USD	99.747%
Todos Medical Ltd.	-9.74 Million USD	99.799%

Global Stocks Search

Bioqual, Inc. (BIOQ)

Operating Income Summary of Bioqual, Inc.

Annual Operating Income Chart of Bioqual, Inc. (2023 - 1995)

Historical Annual Operating Income of Bioqual, Inc. (2023 - 1995)

Peer Operating Income Comparison of Bioqual, Inc.